IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q1 2025 Holdings

Filed 2025-05-09 | 3 holdings | $92.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Maze Therapeutics, Inc.(MAZE)COM578784100$66.9M6,073,95872.0%
Tango Therapeutics, Inc.(TNGX)COM87583X109$23.1M16,859,07524.9%
Pliant Therapeutics, Inc.(PLRX)COM729139105$2.9M2,132,8673.1%